Anagliptin monotherapy in patients with type 2 diabetes mellitus and high low-density lipoprotein cholesterol reduces fasting plasma lathosterol level: a single-arm intervention trial
Yuichi Ikegami, View ORCID ProfileIkuo Inoue, View ORCID ProfileYasuhiro Takenaka, Daigo Saito, Mitsuhiko Noda, View ORCID ProfileAkira Shimada
doi: https://doi.org/10.1101/2020.05.16.20095307
Yuichi Ikegami
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
MD, PhDIkuo Inoue
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
MD, PhDYasuhiro Takenaka
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
bDepartment of Physiology, Graduate School of Medicine, Nippon Medical School, 1-25-16 Nezu, Bunkyo, Tokyo 113-0031, Japan
PhDDaigo Saito
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
MDMitsuhiko Noda
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
MD, PhDAkira Shimada
aDepartment of Endocrinology and Diabetes, Saitama Medical University, Faculty of Medicine, 38 Morohongo, Moroyamacho, Irumagun, Saitama 350-0495, Japan
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 22, 2020.
Anagliptin monotherapy in patients with type 2 diabetes mellitus and high low-density lipoprotein cholesterol reduces fasting plasma lathosterol level: a single-arm intervention trial
Yuichi Ikegami, Ikuo Inoue, Yasuhiro Takenaka, Daigo Saito, Mitsuhiko Noda, Akira Shimada
medRxiv 2020.05.16.20095307; doi: https://doi.org/10.1101/2020.05.16.20095307
Anagliptin monotherapy in patients with type 2 diabetes mellitus and high low-density lipoprotein cholesterol reduces fasting plasma lathosterol level: a single-arm intervention trial
Yuichi Ikegami, Ikuo Inoue, Yasuhiro Takenaka, Daigo Saito, Mitsuhiko Noda, Akira Shimada
medRxiv 2020.05.16.20095307; doi: https://doi.org/10.1101/2020.05.16.20095307
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2531)
- Dermatology (212)
- Emergency Medicine (387)
- Epidemiology (12007)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3924)
- Geriatric Medicine (368)
- Health Economics (656)
- Health Informatics (2536)
- Health Policy (979)
- Hematology (353)
- HIV/AIDS (815)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3682)
- Nursing (205)
- Nutrition (548)
- Oncology (1919)
- Ophthalmology (558)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1079)
- Primary Care Research (436)
- Public and Global Health (6358)
- Radiology and Imaging (1342)
- Respiratory Medicine (848)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (180)
- Urology (158)